clindamycin has been researched along with Ovarian Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corso, S; D'Incalci, M; Frapolli, R; Fruscio, R; Lissoni, AA; Mangioni, C; Zucchetti, M | 1 |
Hancock, KC; Harrison, CR; Satin, AJ; Zahn, CM | 1 |
1 trial(s) available for clindamycin and Ovarian Neoplasms
Article | Year |
---|---|
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients.
Topics: Aged; Antineoplastic Agents, Phytogenic; Clindamycin; Drug Administration Schedule; Drug Interactions; Female; Humans; Metabolic Clearance Rate; Middle Aged; Orosomucoid; Ovarian Neoplasms; Paclitaxel; Protein Binding | 2006 |
1 other study(ies) available for clindamycin and Ovarian Neoplasms
Article | Year |
---|---|
Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy.
Topics: Aged; Ampicillin; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clindamycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Middle Aged; Ovarian Neoplasms; Piperacillin; Recurrence | 1989 |